Coming full circle on IVF

In Alabama, a recent ruling on frozen embryos has raised concerns about the future of IVF treatments. This issue dates back to the anti-abortion movement’s early opposition to IVF, shaping the industry’s development. Despite its immense market demand, IVF remains difficult to access due to limited coverage and high costs. Political interference may further restrict access.

Continue reading

When to start dialysis

Nephrologist Ladan Golestaneh’s research reveals the challenges in managing chronic kidney disease. Patients often resort to dialysis due to limited access to medical care, leading to early dialysis initiation. Golestaneh advocates for incentivizing health systems to prioritize pre-dialysis care, aiming to postpone the need for dialysis and improve patient outcomes.

Continue reading

Stop with the exercise therapy

A study compared the effects of high-intensity cycling on long Covid patients and healthy individuals. Long Covid patients experienced severe tissue damage, impaired muscle cell mitochondria, and an increased accumulation of amyloid-containing deposits after exercise. It suggests that vigorous physical activity can be harmful for long Covid patients, exacerbating their condition. Healthcare workers need to be aware of this and avoid prescribing exercise therapy for such patients.

Continue reading

What is RSV anyway?

RSV, a contagious lung infection, is often mistaken for the flu due to similar symptoms and peaks in winter. It poses severe risks to babies and the elderly, prompting health officials to issue warnings. With increasing cases and insufficient vaccine uptake, precautions like staying home when sick and getting vaccinated are advised. Various vaccines and an RSV monoclonal antibody are available for high-risk groups.

Continue reading

High-fat diets linked to intestinal gene changes impacting immunity and metabolism

High-fat diets have been linked to gene dysregulation, impacting immunity and metabolism in the intestines. Research showed increased expression of host proteins used by COVID-19 to enter the body and potential impact on brain health. The study underscores the need to examine high-fat dietary habits and their long-term effects, especially those involving soybean oil.

Continue reading

Gearing up for better nights

Struggling with long Covid, the writer emphasizes the importance of sleep in managing symptoms. Exploring various strategies, from ergonomic pillows to melatonin, they discuss their ongoing recovery journey. Highlighting the significance of research in understanding and treating long Covid, the writer remains hopeful for improved outcomes. Sleep, diet, and experimentation play crucial roles in their recovery.

Continue reading

Cheaper weight-loss pills

Weight-loss pills like Qsymia offer effective yet less expensive alternatives to newer GLP-1 drugs. While Qsymia has potential side effects, it presents a crucial choice for patients unable to access or tolerate GLP-1s. Despite the potential for reduced side effects, newer drugs remain less accessible due to high costs, leaving patients with limited options.

Continue reading

When Should You Get Screened for Cancer? Here’s the Latest Guidance.

Regular cancer screenings have become increasingly important as cancer rates rise, especially among younger individuals. Guidelines for breast and colorectal cancer screenings have shifted, with recommendations now starting at age 40 and 45 respectively. Additional tests for lung and cervical cancer, as well as genetic risk assessments, are also available, offering opportunities for early detection and intervention.

Continue reading

Vitamin B12 supplementation may improve MS drug therapy, study suggests

A study has found a novel molecular link between vitamin B12 and multiple sclerosis (MS), indicating that the drug fingolimod regulates vitamin B12 pathways, potentially enhancing MS treatments. The research suggests that augmenting brain vitamin B12 could improve therapy outcomes, with implications for other neurodegenerative conditions. This discovery underscores the critical role of vitamin B12 in neurological health and the potential for nutrition-based interventions in MS treatment strategies

Continue reading

Pho and mosquitoes…

The author’s trip to Vietnam, enjoying local foods and facing mosquito bites, brings attention to the dangers of mosquito-borne diseases like malaria and dengue, especially significant due to their long Covid condition. With climate change potentially expanding these threats to new regions, as seen with recent malaria cases in the US, the narrative underscores the importance of precautions against mosquitoes. The return to London’s colder climate offers temporary relief, but the story serves as a caution for travelers in warmer destinations

Continue reading

Covid JN.1 Variant Is Driving Nearly Half of Cases: What to Know, Including Symptoms

The JN.1 Covid-19 variant, an Omicron offshoot, has rapidly spread, accounting for 44% of U.S. cases. The WHO considers it a variant of interest due to its swift global proliferation. Current vaccines and treatments remain effective against JN.1. Health officials emphasize the need for vaccinations, mask-wearing, and hygiene practices, especially during the holidays, as Covid-19, flu, and RSV cases rise. The variant’s spread highlights the ongoing challenge of managing respiratory diseases

Continue reading

A New Way to Treat Back Pain

Pain reprocessing therapy (PRT) is a new approach for chronic pain, teaching the brain to stop sending false pain signals. A study showed 66% of participants had reduced pain after PRT. It combines psychological and physical strategies, including exposure therapy to reevaluate pain sensations. Although in early stages and not widely covered by insurance, PRT is gaining traction as a potential method to address chronic pain by altering brain perceptions and responses

Continue reading

Covid pills 2.0

During the Covid-19 pandemic, scientists worldwide formed the Covid Moonshot to create an open-source antiviral. Despite challenges, including displaced Ukrainian team members, their patent-free treatment is nearing human trials. Led by Annette von Delft of the University of Oxford, this effort aims to provide accessible treatments for Covid and other diseases. While commercial antivirals like Pfizer’s Paxlovid have seen diminished demand, the need for affordable, effective treatments persists amid ongoing virus mutations and case surges

Continue reading

Staying slim after GLP-1 treatment

A recent study reveals that long-term weight management after weight loss with GLP-1 drugs like Zepbound is still largely unknown. While some patients remained lighter after switching to a placebo, many regained about half their lost weight. Insurers’ rules and the high cost of these drugs represent further challenges. Experts call for focused research on weight maintenance strategies.

Continue reading

1 6 7 8 9 10 11